Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
EDGEWELL PERSONAL CARE Co
Report date November 15, 2024 · Filed November 19, 2024
Section 16 reporting ended · disclosed 2024-11-19. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-Qualified Stock Options 11/11/2022SEC Table II · derivative / convertible security · Conversion / exercise price $39.75 · Expires 2032-11-11 | Direct | 8,761 |
Reported balance
After 2024-11-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-11-15 · Other · Disposed 4,380 · Balance 8,761 F1: Unvested award forfeited upon Mr. O'Toole's departure from the Company on November 15, 2024. F2: These options were vested prior to Mr. O'Toole's departure from the Company. He will have 90 days from his departure date to exercise them. |
| Non-Qualified Stock Options 11/12/2021SEC Table II · derivative / convertible security · Conversion / exercise price $43.29 · Expires 2031-11-12 | Direct | 10,267 |
Reported balance
After 2024-11-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-11-15 · Other · Disposed 0 · Balance 10,267 F3: There were no unvested options for this award to forfeit at the time of Mr. O'Toole's departure from the Company. See column 9 for the number of vested and exercisable options at the time of his departure. F2: These options were vested prior to Mr. O'Toole's departure from the Company. He will have 90 days from his departure date to exercise them. |
| Restricted Stock Equivalent 11/11/2022SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2024-11-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-11-15 · Other · Disposed 2,516 · Balance 0 F1: Unvested award forfeited upon Mr. O'Toole's departure from the Company on November 15, 2024. |
| Restricted Stock Equivalent 11/10/2023SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2024-11-15 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-11-15 · Other · Disposed 6,429 · Balance 0 F1: Unvested award forfeited upon Mr. O'Toole's departure from the Company on November 15, 2024. |
| Performance Restricted Stock Equivalents (PRSE) 11/11/2022SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2024-11-15 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2024-11-15 · Other · Disposed 25,158 · Balance 0 F1: Unvested award forfeited upon Mr. O'Toole's departure from the Company on November 15, 2024. |
| Performance Restricted Stock Equivalents (PRSE) 11/10/2023SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2024-11-15 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2024-11-15 · Other · Disposed 32,145 · Balance 0 F1: Unvested award forfeited upon Mr. O'Toole's departure from the Company on November 15, 2024. |
| Non-Qualified Stock Options 11/13/2020SEC Table II · derivative / convertible security · Conversion / exercise price $35.37 · Expires 2030-11-13 | Direct | 5,637 |
Reported balance
After 2024-11-15 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2024-11-15 · Other · Disposed 0 · Balance 5,637 F3: There were no unvested options for this award to forfeit at the time of Mr. O'Toole's departure from the Company. See column 9 for the number of vested and exercisable options at the time of his departure. F2: These options were vested prior to Mr. O'Toole's departure from the Company. He will have 90 days from his departure date to exercise them. |
| Non-Qualified Stock Options Premium 11/13/2020SEC Table II · derivative / convertible security · Conversion / exercise price $38.91 · Expires 2030-11-13 | Direct | 11,795 |
Reported balance
After 2024-11-15 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2024-11-15 · Other · Disposed 0 · Balance 11,795 F3: There were no unvested options for this award to forfeit at the time of Mr. O'Toole's departure from the Company. See column 9 for the number of vested and exercisable options at the time of his departure. F2: These options were vested prior to Mr. O'Toole's departure from the Company. He will have 90 days from his departure date to exercise them. |
| Non-Qualified Stock Options 11/10/2023SEC Table II · derivative / convertible security · Conversion / exercise price $34.22 · Expires 2033-11-14 | Direct | 5,441 |
Reported balance
After 2024-11-15 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2024-11-15 · Other · Disposed 10,880 · Balance 5,441 F1: Unvested award forfeited upon Mr. O'Toole's departure from the Company on November 15, 2024. F2: These options were vested prior to Mr. O'Toole's departure from the Company. He will have 90 days from his departure date to exercise them. |
| Common StockSEC Table I · non-derivative | Direct | 32,391 |
Reported balance
Holding disclosure · report date 2024-11-15 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 32,391 |
Filing footnotes · ownership attribution and instrument terms
F1: Unvested award forfeited upon Mr. O'Toole's departure from the Company on November 15, 2024.
F2: These options were vested prior to Mr. O'Toole's departure from the Company. He will have 90 days from his departure date to exercise them.
F3: There were no unvested options for this award to forfeit at the time of Mr. O'Toole's departure from the Company. See column 9 for the number of vested and exercisable options at the time of his departure.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 15, 2021 Filed Nov 17, 2021 15:33 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | Exercise / conversionRestricted Stock Equivalent 11/13/2020 · Derivative | 2,639 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-064974 · doc4.xml · derivative · entry 3 O'Toole Eric F · CIK 0001813568 · President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,278 Underlying: Common Stock · 2,639 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Restricted stock equivalents vested and converted into shares of EPC common stock on 11/15/2021. F2 · derivative.expiration_date: Restricted stock equivalents vested and converted into shares of EPC common stock on 11/15/2021. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 15:33 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | Tax withholdingCommon Stock | 1,300 | $42.94 | $55,822.00 |
DisclosureSEC source: 0001209191-21-064974 · doc4.xml · nonDerivative · entry 2 O'Toole Eric F · CIK 0001813568 · President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,237 F1 · shares: Shares withheld as payment of a tax liability on vesting of restricted stock equivalents. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 15:33 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | Exercise / conversionCommon Stock | 2,639 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-064974 · doc4.xml · nonDerivative · entry 1 O'Toole Eric F · CIK 0001813568 · President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,537 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 19:14 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantPerformance Restricted Stock Equivalents (PRSE) 11/12/2021 · Derivative | 17,326 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-064671 · doc4.xml · derivative · entry 3 O'Toole Eric F · CIK 0001813568 · President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,326 Underlying: Common Stock · 17,326 shares Expires not disclosed F3 · derivative.exercise_date: The PRSEs will vest and convert into shares of Edgewell common stock on the date that Edgewell releases its earnings for the fiscal year ending September 30, 2024 if the following specified performance criteria is met: Relative Total Shareholder Return for the "Performance Period" beginning on October 1, 2021 and ending on September 30, 2024 (100%). Percentage will range from 0% to 100% based on company performance. The amount shown is the maximum amount available to vest. F3 · derivative.expiration_date: The PRSEs will vest and convert into shares of Edgewell common stock on the date that Edgewell releases its earnings for the fiscal year ending September 30, 2024 if the following specified performance criteria is met: Relative Total Shareholder Return for the "Performance Period" beginning on October 1, 2021 and ending on September 30, 2024 (100%). Percentage will range from 0% to 100% based on company performance. The amount shown is the maximum amount available to vest. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 19:14 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantRestricted Stock Equivalents (RSE) 11/12/2021 · Derivative | 5,198 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-064671 · doc4.xml · derivative · entry 2 O'Toole Eric F · CIK 0001813568 · President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,198 Underlying: Common Stock · 5,198 shares Expires not disclosed F2 · derivative.exercise_date: One-third of the RSEs will vest and convert into shares of Edgewell common stock on each of 11/12/2022, 11/12/2023 and 11/12/2024 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events. F2 · derivative.expiration_date: One-third of the RSEs will vest and convert into shares of Edgewell common stock on each of 11/12/2022, 11/12/2023 and 11/12/2024 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 19:14 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantNon-Qualified Stock Options 11/12/2021 · Derivative | 10,267 | $0.00 Strike: $43.29 | $0.00 |
DisclosureSEC source: 0001209191-21-064671 · doc4.xml · derivative · entry 1 O'Toole Eric F · CIK 0001813568 · President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,267 Underlying: Common Stock · 10,267 shares Expires 2031-11-12 F1 · derivative.exercise_date: One-third of the Options will become exercisable on each of 11/12/2022, 11/12/2023 and 11/12/2024, as long as the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events. Read SEC document |
| November 11, 2021 Filed Nov 12, 2021 19:36 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | Exercise / conversionPerformance Stock Equivalent 7/1/2020 · Derivative | 22,696 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-064114 · doc4.xml · derivative · entry 3 O'Toole Eric F · CIK 0001813568 · President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,696 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Performance stock equivalents vested and converted into shares of EPC common stock on 11/11/2021. The original award was 26,482 shares, but only 22,696 shares of the award were vested in accordance with the performance criteria. The remainder were cancelled. F2 · derivative.expiration_date: Performance stock equivalents vested and converted into shares of EPC common stock on 11/11/2021. The original award was 26,482 shares, but only 22,696 shares of the award were vested in accordance with the performance criteria. The remainder were cancelled. Read SEC document |
| November 11, 2021 Filed Nov 12, 2021 19:36 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | Tax withholdingCommon Stock | 8,606 | $43.45 | $373,930.70 |
DisclosureSEC source: 0001209191-21-064114 · doc4.xml · nonDerivative · entry 2 O'Toole Eric F · CIK 0001813568 · President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,898 F1 · shares: Shares withheld as payment of a tax liability on vesting of performance stock equivalents. Read SEC document |
| November 11, 2021 Filed Nov 12, 2021 19:36 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | Exercise / conversionCommon Stock | 22,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-064114 · doc4.xml · nonDerivative · entry 1 O'Toole Eric F · CIK 0001813568 · President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 14:53 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | Exercise / conversionRestricted Stock Equivalent 7/1/2020 · Derivative | 5,793 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-045258 · doc4.xml · derivative · entry 3 O'Toole Eric F · CIK 0001813568 · President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,793 Underlying: Common Stock · 5,793 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Restricted stock equivalents vested and converted into shares of EPC common stock on 7/1/2021. F2 · derivative.expiration_date: Restricted stock equivalents vested and converted into shares of EPC common stock on 7/1/2021. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 14:53 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | Tax withholdingCommon Stock | 1,985 | $43.56 | $86,466.60 |
DisclosureSEC source: 0001209191-21-045258 · doc4.xml · nonDerivative · entry 2 O'Toole Eric F · CIK 0001813568 · President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,808 F1 · shares: Shares withheld as payment of a tax liability on vesting of restricted stock equivalents. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 14:53 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | Exercise / conversionCommon Stock | 5,793 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-045258 · doc4.xml · nonDerivative · entry 1 O'Toole Eric F · CIK 0001813568 · President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,793 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 19:38 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantPerformance Restricted Stock Equivalents (PRSE) 11/13/2020 · Derivative | 11,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058680 · doc4.xml · derivative · entry 4 O'Toole Eric F · CIK 0001813568 · President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,875 Underlying: Common Stock · 11,875 shares Expires not disclosed F3 · derivative.exercise_date: The PRSEs will vest and convert into shares of Edgewell common stock on the date that Edgewell releases its earnings for the fiscal year ending September 30, 2023 if the following specified performance criteria is met: Relative Total Shareholder Return for the "Performance Period" beginning on October 1, 2020 and ending on September 30, 2023 (100%). Percentage will range from 0% to 100% based on company performance. F3 · derivative.expiration_date: The PRSEs will vest and convert into shares of Edgewell common stock on the date that Edgewell releases its earnings for the fiscal year ending September 30, 2023 if the following specified performance criteria is met: Relative Total Shareholder Return for the "Performance Period" beginning on October 1, 2020 and ending on September 30, 2023 (100%). Percentage will range from 0% to 100% based on company performance. Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 19:38 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantRestricted Stock Equivalents (RSE) 11/13/2020 · Derivative | 7,917 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-058680 · doc4.xml · derivative · entry 3 O'Toole Eric F · CIK 0001813568 · President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,917 Underlying: Common Stock · 7,917 shares Expires not disclosed F2 · derivative.exercise_date: One-third of the RSEs will vest and convert into shares of Edgewell common stock on each of 11/13/2021, 11/13/2022 and 11/13/2023 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events. F2 · derivative.expiration_date: One-third of the RSEs will vest and convert into shares of Edgewell common stock on each of 11/13/2021, 11/13/2022 and 11/13/2023 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events. Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 19:38 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantNon-Qualified Stock Options (Premium) 11-13-2020 · Derivative | 11,795 | $0.00 Strike: $38.91 | $0.00 |
DisclosureSEC source: 0001209191-20-058680 · doc4.xml · derivative · entry 2 O'Toole Eric F · CIK 0001813568 · President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,795 Underlying: Common Stock · 11,795 shares Expires 2030-11-13 F1 · derivative.exercise_date: One-third of the Options will become exercisable on each of 11/13/2021, 11/13/2022 and 11/13/2023, as long as the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events. Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 19:38 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantNon-Qualified Stock Options 11/13/2020 · Derivative | 5,637 | $0.00 Strike: $35.37 | $0.00 |
DisclosureSEC source: 0001209191-20-058680 · doc4.xml · derivative · entry 1 O'Toole Eric F · CIK 0001813568 · President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,637 Underlying: Common Stock · 5,637 shares Expires 2030-11-13 F1 · derivative.exercise_date: One-third of the Options will become exercisable on each of 11/13/2021, 11/13/2022 and 11/13/2023, as long as the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 23:21 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantPerformance Stock Equivalents (PSE) 7-1-2020 · Derivative | 26,482 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-041265 · doc4.xml · derivative · entry 2 O'Toole Eric F · CIK 0001813568 · President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,482 Underlying: Common Stock · 26,482 shares Expires not disclosed F2 · derivative.exercise_date: The PSEs will vest and convert into shares of Edgewell common stock on the date that Edgewell releases its earnings for the fiscal year ending September 30, 2021 if specified performance criteria are met, subject to the exercise of negative discretion by the Compensation Committee of Edgewell's Board of Directors. The performance goal for the PSEs is the achievement of targeted Project Fuel savings for the period ending September 30, 2021. Percentage will range from 0% to 100% based on company performance. F2 · derivative.expiration_date: The PSEs will vest and convert into shares of Edgewell common stock on the date that Edgewell releases its earnings for the fiscal year ending September 30, 2021 if specified performance criteria are met, subject to the exercise of negative discretion by the Compensation Committee of Edgewell's Board of Directors. The performance goal for the PSEs is the achievement of targeted Project Fuel savings for the period ending September 30, 2021. Percentage will range from 0% to 100% based on company performance. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 23:21 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantRestricted Stock Equivalents (RSE) 7-1-2020 · Derivative | 11,586 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-041265 · doc4.xml · derivative · entry 1 O'Toole Eric F · CIK 0001813568 · President, North America 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,586 Underlying: Common Stock · 11,586 shares Expires not disclosed F1 · derivative.exercise_date: One-half of the RSEs will vest and convert into shares of Edgewell common stock on each of 7/1/2021 and 7/1/2022 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events. F1 · derivative.expiration_date: One-half of the RSEs will vest and convert into shares of Edgewell common stock on each of 7/1/2021 and 7/1/2022 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.